Modification of dopamine transporter function: Effect of reactive oxygen species and dopamine

Journal of Neurochemistry

Volumn 67, Issue 2, 1996, Pages 593-600

  Berman, Sarah B ^a   Zigmond, Michael J ^a   Hastings, Teresa G ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Ascorbate; Dopamine uptake; Free radicals; Neurotoxicity; Parkinson's disease; Quinones

Indexed keywords

ASCORBIC ACID; DOPAMINE; DOPAMINE RECEPTOR; IRON BINDING PROTEIN; LACTATE DEHYDROGENASE; PENTETIC ACID; REACTIVE OXYGEN METABOLITE; XANTHINE; XANTHINE OXIDASE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; ENZYME RELEASE; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; SYNAPTOSOME;

ANIMALIA;

EID: 0030056223     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67020593.x     Document Type: Article

References (52)

1. Amara S. G. and Kuhar M. J. (1993) Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16, 73-93.
2. Bradford M. A. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
3. Braughler J. M. and Hall E. D. (1989) Central nervous system trauma and stroke: I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic. Biol. Med. 6, 289-301.
4. Cao C. J., Young M. M., Wong J. B., Mahran L. G., and Eldefrawi M. E. (1989) Putative cocaine receptor in striatum is a glycoprotein with active thiol function. Membr. Biochem. 8, 207-220.
5. Carney J. M., Starke-Reed P. E., Oliver C. N., Landum R. W., Cheng M. S., Wu J. F., and Floyd R. A. (1991) Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-α-phenylnitrone. Proc. Natl. Acad. Sci. USA 88, 3633-3636.
6. Cleland W. W. (1964) Dithiothreitol, a new protective reagent for SH groups. Biochemistry 3, 480-485.
7. Dabrowiecki Z., Gordon-Majszak W., and Lazarewicz J. (1985) Effects of lipid peroxidation on neurotransmitter uptake by rat synaptosomes. Pol. J. Pharmacol. 37, 325-331.
8. Davies K. J. A., Delsignore M. E., and Lin S. W. (1987) Protein damage and degradation by oxygen radicals: II. Modification of amino acids. J. Biol. Chem. 262, 9902-9907.
9. +: implications for neurodegeneration. J. Neurochem. 63, 584-591.
10. Filloux F. and Townsend J. J. (1993) Pre- and post-synaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp. Neurol. 119, 79-88.
11. Fornstedt B., Bergh I., Rosengren E., and Carlsson A. (1990) An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. J. Neurochem. 54, 578-586.
12. Giros B., El Mestikawy S., Bertrand L., and Caron M. G. (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295, 149-154.
13. Giros B., El Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., and Caron M. G. (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42, 383-390.
14. Giros B., Jaber M., Jones S. R., Wightman M. R., and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
15. Götz M. E., Künig G., Riederer P., and Youdim M. B. H. (1994) Oxidative stress: free radical production in neural degeneration. Pharmacol. Ther. 63, 37-122.
16. Graham D. G. (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643.
17. Graham D. G., Tiffany S. M., Bell W. R. Jr., and Gutknecht W. F. (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14, 644-653.
18. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
19. Hastings T. G. (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J. Neurochem. 64, 919-924.
20. 3H]-dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 63, 1126-1132.
21. Hastings T. G., Lewis D., and Zigmond M. J. (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93, 1956-1961.
22. 3H] dopamine antagonists to neostriatal membrane preparations: relationship to lipid peroxidation. J. Neurochem. 38, 1000-1006.
23. Javitch J. A., D'Amato R. J., Strittmatter S. M., and Snyder S. H. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82, 2173-2177.
24. Jonsson G. and Sachs C. (1970) Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons. Eur. J. Pharmacol. 9, 141-155.
25. Keynan S. and Kanner B. (1988) γ-Aminobutyric acid transport in reconstituted preparations from rat brain: coupled sodium and chloride fluxes. Biochemistry 27, 12-17.
26. Kilty J. E., Lorang D., and Amara S. G. (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254, 578-579.
27. Lester H. A., Mager S., Quick M. W., and Corey J. L. (1994) Permeation properties of neurotransmitter transporters. Annu. Rev. Pharmacol. Toxicol. 34, 219-249.
28. 3H] glutamate by striatal synaptosomes. J. Neurochem. 63, 2108-2117.
29. Maker H. S., Weiss C., Silides D. J., and Cohen G. (1981) Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem. 36, 589-593.
30. McCord J. M. and Fridovich I. (1969) Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244, 6049-6055.
31. Michel P. P. and Hefti F. (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26, 428-435.
32. 3H]spiperone binding consequent to lipid peroxidation in rat cortical membranes. Biochem. Biophys. Res. Commun. 104, 1003-1010.
33. Nelson S. D. and Pearson P. G. (1990) Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu. Rev. Pharmacol. Toxicol. 30, 169-195.
34. 3H]dopamine uptake. Brain Res. 641, 83-91.
35. Rafalowska U., Liu G.-J., and Floyd R. A. (1989) Peroxidation induced changes in synaptosomal transport of dopamine and γ-aminobutyric acid. Free Radic. Biol. Med. 6, 485-492.
36. Ramassamy C., Naudin G., Christen Y., Clostre R, and Costentin J. (1992) Prevention by ginkgo biloba extract (EGb 761) and trolox C of the decrease in synaptosomal dopamine or serotonin uptake following incubation. Biochem. Pharmacol. 44, 2395-2401.
37. Scheuch C. H., Berndt C. H., Gross J., Poulsen J. P., Saugstad D. O., and Haberland A. (1989) Influence of the hypoxanthine/ xanthine oxidase system on striatal (3H) dopamine uptake. Biomed. Biochim. Acta 48, S212-S216.
38. Schoemaker H. and Nickolson V. J. (1983) Dopamine uptake by rat striatal synaptosomes: time- and temperature-dependent decay and protection by dithiothreitol and dopamine. J. Neurochem. 40, 922-928.
39. 3H]threo-(±)-methylphenidate to the stimulant recognition site. Neuropharmacology 29, 901-908.
40. Shafqat S., Velaz-Faircloth M., Guadano-Ferraz A., and Fremeau R. T. (1993) Molecular characterization of neurotransmitter transporters. Mol. Endocrinol. 7, 1517-1529.
41. Shimada S., Kitayama S., Lin C.-L., Patel A., Nanthakumar E., Gregor P., Kuhar M., and Uhl G. (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578.
42. 3H] dopamine uptake in rat striatum during aging. J. Neurochem. 56, 575-579.
43. Stadtman E. R. (1991) Ascorbic acid and oxidative inactivation of proteins. Am. J. Clin. Nutr. 54, 1125S-1128S.
44. Stadtman E. R. (1992) Protein oxidation and aging. Science 257, 1220-1224.
45. +)-stimulated ATPase in brain: separation, and difference in affinity for strophanthidin. J. Biol. Chem. 254, 6060-6067.
46. Tse D. C. S., McCreery R. L., and Adams R. N. (1976) Potential oxidative pathways of brain catecholamines. J. Med. Chem. 19, 37-40.
47. Vandenbergh D. J., Persico A. M., and Uhl G. R. (1992) A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element, and provides racially-dimorphic Taq I RFLPs. Mol. Brain Res. 15, 161-166.
48. Volterra A., Trotti D., Tromba C., Floridi S., and Racagni G. (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
49. Wang J. B., Moriwaki A., and Uhl G. R. (1995) Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression. J. Neurochem. 64, 1416-1419.
50. Wheeler D. D., Edwards A. M., and Ondo J. G. (1993) Dopamine uptake in five structures of the brain: comparison of rate, sodium dependence and sensitivity to cocaine. Neuropharmacology 32, 501-508.
51. Wroblewski F. and LaDue J. S. (1955) Lactic acid dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90, 210-215.
52. 3H]dopamine. Neuropharmacology 29, 475-486.